Cargando…

Biotinidase deficiency: clinical and genetic studies of 38 Brazilian patients

BACKGROUND: Biotinidase deficiency (BD) is an inborn error of metabolism in which some genetic variants correlate with the level of enzyme activity. Biotinidase activity, however, may be artifactually low due to enzyme lability, premature birth, and jaundice; this hinders both phenotypic classificat...

Descripción completa

Detalles Bibliográficos
Autores principales: Borsatto, Taciane, Sperb-Ludwig, Fernanda, Pinto, Louise LC, De Luca, Gisele R, Carvalho, Francisca L, De Souza, Carolina FM, De Medeiros, Paula FV, Lourenço, Charles M, Filho, Reinaldo LO, Neto, Eurico C, Bernardi, Pricila, Leistner-Segal, Sandra, Schwartz, Ida VD
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4236587/
https://www.ncbi.nlm.nih.gov/pubmed/25174816
http://dx.doi.org/10.1186/s12881-014-0096-3
_version_ 1782345196209438720
author Borsatto, Taciane
Sperb-Ludwig, Fernanda
Pinto, Louise LC
De Luca, Gisele R
Carvalho, Francisca L
De Souza, Carolina FM
De Medeiros, Paula FV
Lourenço, Charles M
Filho, Reinaldo LO
Neto, Eurico C
Bernardi, Pricila
Leistner-Segal, Sandra
Schwartz, Ida VD
author_facet Borsatto, Taciane
Sperb-Ludwig, Fernanda
Pinto, Louise LC
De Luca, Gisele R
Carvalho, Francisca L
De Souza, Carolina FM
De Medeiros, Paula FV
Lourenço, Charles M
Filho, Reinaldo LO
Neto, Eurico C
Bernardi, Pricila
Leistner-Segal, Sandra
Schwartz, Ida VD
author_sort Borsatto, Taciane
collection PubMed
description BACKGROUND: Biotinidase deficiency (BD) is an inborn error of metabolism in which some genetic variants correlate with the level of enzyme activity. Biotinidase activity, however, may be artifactually low due to enzyme lability, premature birth, and jaundice; this hinders both phenotypic classification and the decision to implement therapy. This study sought to characterize the clinical and genetic profile of a sample of Brazilian patients exhibiting reduced biotinidase activity. METHODS: This observational, multicenter study used a convenience sampling strategy, with sequencing of exons 2, 3, and 4 of the BTD gene. RESULTS: The sample comprised 38 individuals with biochemical phenotypes defined a priori on the basis of biotinidase activity in serum/plasma (2 with profound deficiency, 9 with partial deficiency, 15 heterozygous, 1 borderline between partial deficiency and heterozygosity, 2 borderline between heterozygous and normal) or dried blood spot sample (n = 9, all with unspecified deficiency). Most patients were from Southern Brazil (n = 29/38) and were identified by neonatal screening (n = 33/38). Parental consanguinity was reported in two cases. The most commonly found genetic variants were c.1330G > C (p.D444H), c.755A > G (p.D252G), and c.[511G > A;1330G > C] (p.[A171T;D444H]), with allele frequencies of 50%, 9.4%, and 5.4% respectively. Three novel pathogenic variants were identified (c.119 T > C or p.L40P, c.479G > A or p.C160Y, and c.664G > A or p.D222N). Twenty-nine patients had two pathogenic variants detected (with cis/trans status ascertained in 26/29), six had only one variant, and three had no pathogenic variants detected. Genotyping confirmed the original phenotypic classification based on enzyme activity in 16/26 cases. Three polymorphic variants were identified in control individuals, of which two were nonpathogenic (c.1171C > T or p.P391S and c.1413 T > C or p.C471C, with a frequency of 1.5% and 5.5% respectively) and one pathogenic (c.1330G > C, frequency 4%). CONCLUSIONS: Our findings suggest that partial BD is the most common form of BD in Brazil, and expand current knowledge on the allelic heterogeneity of this condition.
format Online
Article
Text
id pubmed-4236587
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-42365872014-11-19 Biotinidase deficiency: clinical and genetic studies of 38 Brazilian patients Borsatto, Taciane Sperb-Ludwig, Fernanda Pinto, Louise LC De Luca, Gisele R Carvalho, Francisca L De Souza, Carolina FM De Medeiros, Paula FV Lourenço, Charles M Filho, Reinaldo LO Neto, Eurico C Bernardi, Pricila Leistner-Segal, Sandra Schwartz, Ida VD BMC Med Genet Research Article BACKGROUND: Biotinidase deficiency (BD) is an inborn error of metabolism in which some genetic variants correlate with the level of enzyme activity. Biotinidase activity, however, may be artifactually low due to enzyme lability, premature birth, and jaundice; this hinders both phenotypic classification and the decision to implement therapy. This study sought to characterize the clinical and genetic profile of a sample of Brazilian patients exhibiting reduced biotinidase activity. METHODS: This observational, multicenter study used a convenience sampling strategy, with sequencing of exons 2, 3, and 4 of the BTD gene. RESULTS: The sample comprised 38 individuals with biochemical phenotypes defined a priori on the basis of biotinidase activity in serum/plasma (2 with profound deficiency, 9 with partial deficiency, 15 heterozygous, 1 borderline between partial deficiency and heterozygosity, 2 borderline between heterozygous and normal) or dried blood spot sample (n = 9, all with unspecified deficiency). Most patients were from Southern Brazil (n = 29/38) and were identified by neonatal screening (n = 33/38). Parental consanguinity was reported in two cases. The most commonly found genetic variants were c.1330G > C (p.D444H), c.755A > G (p.D252G), and c.[511G > A;1330G > C] (p.[A171T;D444H]), with allele frequencies of 50%, 9.4%, and 5.4% respectively. Three novel pathogenic variants were identified (c.119 T > C or p.L40P, c.479G > A or p.C160Y, and c.664G > A or p.D222N). Twenty-nine patients had two pathogenic variants detected (with cis/trans status ascertained in 26/29), six had only one variant, and three had no pathogenic variants detected. Genotyping confirmed the original phenotypic classification based on enzyme activity in 16/26 cases. Three polymorphic variants were identified in control individuals, of which two were nonpathogenic (c.1171C > T or p.P391S and c.1413 T > C or p.C471C, with a frequency of 1.5% and 5.5% respectively) and one pathogenic (c.1330G > C, frequency 4%). CONCLUSIONS: Our findings suggest that partial BD is the most common form of BD in Brazil, and expand current knowledge on the allelic heterogeneity of this condition. BioMed Central 2014-09-01 /pmc/articles/PMC4236587/ /pubmed/25174816 http://dx.doi.org/10.1186/s12881-014-0096-3 Text en Copyright © 2014 Borsatto et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Borsatto, Taciane
Sperb-Ludwig, Fernanda
Pinto, Louise LC
De Luca, Gisele R
Carvalho, Francisca L
De Souza, Carolina FM
De Medeiros, Paula FV
Lourenço, Charles M
Filho, Reinaldo LO
Neto, Eurico C
Bernardi, Pricila
Leistner-Segal, Sandra
Schwartz, Ida VD
Biotinidase deficiency: clinical and genetic studies of 38 Brazilian patients
title Biotinidase deficiency: clinical and genetic studies of 38 Brazilian patients
title_full Biotinidase deficiency: clinical and genetic studies of 38 Brazilian patients
title_fullStr Biotinidase deficiency: clinical and genetic studies of 38 Brazilian patients
title_full_unstemmed Biotinidase deficiency: clinical and genetic studies of 38 Brazilian patients
title_short Biotinidase deficiency: clinical and genetic studies of 38 Brazilian patients
title_sort biotinidase deficiency: clinical and genetic studies of 38 brazilian patients
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4236587/
https://www.ncbi.nlm.nih.gov/pubmed/25174816
http://dx.doi.org/10.1186/s12881-014-0096-3
work_keys_str_mv AT borsattotaciane biotinidasedeficiencyclinicalandgeneticstudiesof38brazilianpatients
AT sperbludwigfernanda biotinidasedeficiencyclinicalandgeneticstudiesof38brazilianpatients
AT pintolouiselc biotinidasedeficiencyclinicalandgeneticstudiesof38brazilianpatients
AT delucagiseler biotinidasedeficiencyclinicalandgeneticstudiesof38brazilianpatients
AT carvalhofranciscal biotinidasedeficiencyclinicalandgeneticstudiesof38brazilianpatients
AT desouzacarolinafm biotinidasedeficiencyclinicalandgeneticstudiesof38brazilianpatients
AT demedeirospaulafv biotinidasedeficiencyclinicalandgeneticstudiesof38brazilianpatients
AT lourencocharlesm biotinidasedeficiencyclinicalandgeneticstudiesof38brazilianpatients
AT filhoreinaldolo biotinidasedeficiencyclinicalandgeneticstudiesof38brazilianpatients
AT netoeuricoc biotinidasedeficiencyclinicalandgeneticstudiesof38brazilianpatients
AT bernardipricila biotinidasedeficiencyclinicalandgeneticstudiesof38brazilianpatients
AT leistnersegalsandra biotinidasedeficiencyclinicalandgeneticstudiesof38brazilianpatients
AT schwartzidavd biotinidasedeficiencyclinicalandgeneticstudiesof38brazilianpatients